For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Feb 04, 2026  1 hour, 37 minutes ago

Curcumin Shows Promise Against Childhood Leukemia

7314 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Curcumin Shows Promise Against Childhood Leukemia
Nikhil Prasad  Fact checked by:Thailand Medical News Team Feb 04, 2026  1 hour, 37 minutes ago
Medical News: A growing body of scientific evidence is pointing toward a familiar kitchen spice as a potential ally in the fight against one of the most common childhood cancers. Curcumin, the natural yellow compound found in turmeric, has demonstrated strong anti-cancer activity against acute lymphoblastic leukemia in laboratory and animal studies, according to a newly published systematic review.


Curcumin found in turmeric may one day help strengthen leukemia treatment by weakening cancer
cells while sparing healthy ones


Understanding Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia, often called ALL, is a cancer of the blood and bone marrow that mainly affects children but can also occur in adults. It develops when immature white blood cells grow uncontrollably, crowding out healthy cells. While modern chemotherapy has dramatically improved survival rates, many patients still experience severe side effects, drug resistance, or relapse, especially older patients and those with aggressive disease.
 
Why Scientists Are Studying Curcumin
Curcumin is a natural substance extracted from the turmeric plant, long used in traditional medicine and cooking. Scientists have been interested in curcumin for years because it shows anti-inflammatory, antioxidant, and anti-cancer effects in many diseases. This Medical News report focuses on a comprehensive review that examined how curcumin affects ALL cells across laboratory experiments, animal models, and limited patient derived samples.
 
How Curcumin Attacks Leukemia Cells
The review analyzed 26 scientific studies and found that curcumin consistently slowed the growth of leukemia cells and triggered a process known as programmed cell death. In simple terms, curcumin appears to push cancer cells to self-destruct while largely sparing healthy cells.
 
Researchers found that curcumin damages leukemia cells by increasing internal stress, disrupting energy producing structures inside the cell, and activating enzymes that dismantle the cell from within. It also interferes with powerful growth signaling pathways that leukemia cells rely on to survive and multiply. Importantly, curcumin reduced the activity of genes linked to drug resistance, suggesting it may help make cancer cells more sensitive to existing treatments.
 
Evidence From Animal and Patient Samples
Animal studies were limited but encouraging. In one experiment, curcumin reduced leukemia spread in mice and lowered levels of a cancer-causing gene associated with aggressive leukemia. Studies using bone marrow cells from leukemia patients also showed that curcumin reduced the expression of genes linked to relapse and treatment failure.
 
However, the researchers stressed that no large-scale human clinical trials have yet tested curcumin as a treatment for ALL, meaning its real-world effectiveness remains unproven.
 
Major Limitation Researchers Highlight
One major challenge is that curcumin is poorly absorbed by the human body. Even large doses often result in very low levels in the bloodstream. Scientists believe future research must focus on improving curcumin formulations so it can be delivered more effectively and safely to patients.
 
Institutions Involved in the Research
The researchers are from the Jeffrey Cheah School of Medicine and Health Sciences at Monash University Malaysia, Monash Medical Centre and Monash Health in Melbourne Australia, and Maharaj Nakorn Chiang Mai Hospital in Thailand.
 
Conclusions
Overall, the review concludes that curcumin shows strong and consistent anti leukemia effects in laboratory studies and early animal research. While it is not ready to replace existing treatments, it may one day be used alongside standard therapies to reduce drug resistance and side effects. Well-designed clinical trials and improved delivery methods are now essential before curcumin can be considered for routine leukemia care.
 
The study findings were published in the peer reviewed journal: Biology.
https://www.mdpi.com/2079-7737/15/3/258
 
For the latest on herbs and phytochemicals, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/articles/herbs-and-phytochemicals
 
https://www.thailandmedical.news/articles/cancer
 

MOST READ

Feb 01, 2026  3 days ago
Nikhil Prasad
Jan 31, 2026  4 days ago
Nikhil Prasad
Jan 27, 2026  8 days ago
Nikhil Prasad
Jan 27, 2026  8 days ago
Nikhil Prasad
Jan 26, 2026  9 days ago
Nikhil Prasad
Jan 25, 2026  10 days ago
Nikhil Prasad
Jan 24, 2026  11 days ago
Nikhil Prasad
Jan 23, 2026  13 days ago
Nikhil Prasad
Jan 22, 2026  13 days ago
Nikhil Prasad
Jan 21, 2026  14 days ago
Nikhil Prasad
Jan 20, 2026  15 days ago
Nikhil Prasad
Jan 18, 2026  17 days ago
Nikhil Prasad
Jan 18, 2026  17 days ago
Nikhil Prasad
Jan 17, 2026  18 days ago
Nikhil Prasad
Jan 14, 2026  21 days ago
Nikhil Prasad
Jan 14, 2026  22 days ago
Nikhil Prasad
Jan 13, 2026  22 days ago
Nikhil Prasad
Jan 12, 2026  23 days ago
Nikhil Prasad
Jan 12, 2026  24 days ago
Nikhil Prasad

FROM THAILAND BIOTECH NEWS

LATEST ON GENOMICS AND EPIGENETICS